Frazier Life Sciences Management »

Adverum Biotechnologies shares owned by Frazier Life Sciences Management

Quarter-by-quarter ownership of Adverum Biotechnologies shares owned by Frazier Life Sciences Management from 13F filings

Historical chart of Frazier Life Sciences Management investment in Adverum Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Adverum Biotechnologies held by Frazier Life Sciences Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adverum Biotechnologies by Frazier Life Sciences Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $15M 1.1M 14.14

More positions owned by Frazier Life Sciences Management

Newamsterdam Pharma Company Ordinary Shares (NAMS)
Mirum Pharmaceuticals (MIRM)
Krystal Biotech (KRYS)
Hillevax (HLVX)
Phathom Pharmaceuticals (PHAT)
Rhythm Pharmaceuticals (RYTM)
Bridgebio Pharma (BBIO)
Arcutis Biotherapeutics (ARQT)
Disc Medicine (IRON)
Vaxcyte (PCVX)
Edgewise Therapeutics (EWTX)
Anaptysbio Inc Common (ANAB)
Verona Pharma Sponsored Ads (VRNA)
Kalvista Pharmaceuticals (KALV)
Tarsus Pharmaceuticals (TARS)

View all positions for Frazier Life Sciences Management

Top funds holding Adverum Biotechnologies

TCG Crossover Management
Versant Venture Management

View all funds holding Adverum Biotechnologies